Paralel Advisors LLC Takes Position in Universal Health Services, Inc. $UHS

Paralel Advisors LLC bought a new stake in Universal Health Services, Inc. (NYSE:UHSFree Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 12,903 shares of the health services provider’s stock, valued at approximately $1,919,000.

A number of other institutional investors have also added to or reduced their stakes in the company. Elyxium Wealth LLC bought a new stake in shares of Universal Health Services during the fourth quarter valued at approximately $25,000. CYBER HORNET ETFs LLC bought a new stake in Universal Health Services in the 2nd quarter valued at $29,000. Elevation Wealth Partners LLC increased its holdings in Universal Health Services by 503.1% in the 2nd quarter. Elevation Wealth Partners LLC now owns 193 shares of the health services provider’s stock valued at $29,000 after buying an additional 161 shares during the period. MUFG Securities EMEA plc acquired a new position in shares of Universal Health Services in the 2nd quarter valued at $31,000. Finally, Larson Financial Group LLC raised its stake in shares of Universal Health Services by 302.9% in the 4th quarter. Larson Financial Group LLC now owns 141 shares of the health services provider’s stock valued at $31,000 after buying an additional 106 shares in the last quarter. 86.05% of the stock is owned by institutional investors and hedge funds.

Universal Health Services Price Performance

Universal Health Services stock opened at $169.43 on Monday. Universal Health Services, Inc. has a 52 week low of $140.08 and a 52 week high of $246.32. The firm has a market cap of $9.99 billion, a P/E ratio of 6.90, a P/E/G ratio of 0.91 and a beta of 1.06. The company has a debt-to-equity ratio of 0.54, a quick ratio of 1.04 and a current ratio of 1.12. The business’s fifty day moving average is $163.60 and its two-hundred day moving average is $171.30.

Universal Health Services (NYSE:UHSGet Free Report) last released its quarterly earnings results on Tuesday, July 28th. The health services provider reported $5.98 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.94 by $0.04. The business had revenue of $4.64 billion during the quarter, compared to analysts’ expectations of $4.58 billion. Universal Health Services had a return on equity of 19.39% and a net margin of 8.42%.The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. During the same period in the previous year, the business posted $5.35 earnings per share. Equities research analysts forecast that Universal Health Services, Inc. will post 22.96 earnings per share for the current fiscal year.

Universal Health Services Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a $0.20 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.5%. Universal Health Services’s payout ratio is currently 3.26%.

Analyst Ratings Changes

Several analysts have recently weighed in on UHS shares. UBS Group reiterated a “buy” rating on shares of Universal Health Services in a research report on Monday, August 31st. Morgan Stanley cut their price target on shares of Universal Health Services from $212.00 to $191.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 29th. JPMorgan Chase & Co. decreased their price objective on Universal Health Services from $235.00 to $205.00 and set a “neutral” rating on the stock in a report on Wednesday, May 20th. Guggenheim dropped their target price on Universal Health Services from $195.00 to $189.00 and set a “buy” rating for the company in a report on Wednesday, July 29th. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a $183.00 target price on shares of Universal Health Services in a research report on Thursday, August 20th. Five research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. According to data from MarketBeat.com, Universal Health Services currently has an average rating of “Hold” and a consensus price target of $204.93.

Check Out Our Latest Report on Universal Health Services

About Universal Health Services

(Free Report)

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.

Featured Articles

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHSFree Report).

Institutional Ownership by Quarter for Universal Health Services (NYSE:UHS)

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.